PharmaEssentia Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	268,140	204,725	114,578	143,840	78,065	24,709
Market Cap Growth	11.72%	78.68%	-20.34%	84.26%	215.94%	2.44%
Enterprise Value	247,451	184,915	94,836	140,322	77,603	21,027
Last Close Price	725.00	552.99	311.12	428.91	260.17	83.29
PE Ratio	55.99	69.04	-	-	-	-
Forward PE	38.12	41.36	31.89	69.03	-	-
PS Ratio	19.41	21.03	22.44	49.91	118.91	44.34
PB Ratio	9.01	7.45	4.78	11.85	18.37	6.30
P/TBV Ratio	9.09	7.53	4.84	12.08	19.50	6.68
P/FCF Ratio	88.63	121.51	-	-	-	-
P/OCF Ratio	62.14	80.38	-	-	-	-
EV/Sales Ratio	17.91	19.00	18.58	48.69	118.21	37.73
EV/EBITDA Ratio	58.21	100.14	-	-	-	-
EV/EBIT Ratio	63.35	106.51	-	-	-	-
EV/FCF Ratio	81.79	109.75	-	-	-	-
Debt / Equity Ratio	0.03	0.04	0.05	0.13	0.13	0.17
Debt / EBITDA Ratio	0.21	0.47	-	-	-	-
Debt / FCF Ratio	0.30	0.57	-	-	-	-
Asset Turnover	0.43	0.33	0.24	0.27	0.11	0.13
Inventory Turnover	1.22	0.86	0.48	0.83	0.60	1.15
Quick Ratio	6.45	9.34	9.86	4.37	2.80	3.37
Current Ratio	6.83	9.94	10.64	5.24	3.49	3.82
Return on Equity (ROE)	17.21%	11.54%	-3.46%	-16.77%	-68.81%	-63.10%
Return on Assets (ROA)	7.68%	3.72%	-5.61%	-11.77%	-30.08%	-25.26%
Return on Invested Capital (ROIC)	43.99%	26.72%	-43.05%	-85.59%	-210.08%	-130.09%
Return on Capital Employed (ROCE)	12.80%	6.10%	-7.60%	-15.90%	-59.00%	-38.60%
Earnings Yield	1.79%	1.45%	-0.54%	-0.96%	-3.60%	-7.88%
FCF Yield	1.13%	0.82%	-1.74%	-1.26%	-3.24%	-6.22%
Dividend Yield	0.14%	0.18%	-	-	-	-
Buyback Yield / Dilution	-0.44%	-3.59%	-13.47%	-9.24%	-7.39%	-10.55%
Total Shareholder Return	-0.30%	-3.41%	-13.47%	-9.24%	-7.39%	-10.55%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.